SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-136922
Filing Date
2021-11-10
Accepted
2021-11-10 16:00:54
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20210930x10q.htm   iXBRL 10-Q 1262975
2 EXHIBIT 31.1 atxs-20210930xex31d1.htm EX-31.1 11072
3 EXHIBIT 31.2 atxs-20210930xex31d2.htm EX-31.2 10952
4 EXHIBIT 32.1 atxs-20210930xex32d1.htm EX-32.1 7272
  Complete submission text file 0001104659-21-136922.txt   5454964

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atxs-20210930.xsd EX-101.SCH 44605
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxs-20210930_cal.xml EX-101.CAL 42020
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxs-20210930_def.xml EX-101.DEF 185597
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20210930_lab.xml EX-101.LAB 386508
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20210930_pre.xml EX-101.PRE 303248
10 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20210930x10q_htm.xml XML 864334
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 211396407
SIC: 2834 Pharmaceutical Preparations